MedPath

The development of new diagnostic tools in food allergy

Withdrawn
Conditions
food hypersensitivity
food allergy
10001708
Registration Number
NL-OMON34148
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adults (from 18 years) with a (suspicion of) legume (peanut, soy), nut (hazel nut, pecan nut, cashew nut, walnut), cow's milk, fish, egg, shrimp or latex allergy

Exclusion Criteria

congenital/acquired immunodeficiency
lymphoproliferative disease
systemic immunosuppression
Only when patients will undergo a food challenge:
instabile asthma
contra-indication for treatment with epinephrine (instabile angina pectoris, poor controlled hypertension or arrhythmia)
use of β-blocker or ACE inhibitor
pregnancy

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To develop a model to predict (the severity of) a food allergy. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>-New biomarker(s) that can predict (the severity of) a food allergy<br /><br>-To compare sensitivity, specificity and positive and negative predictive value<br /><br>for different diagnostic tests: allergen chip, CAP, skin prick tests, basophil<br /><br>activation test (BAT) and T cell activity<br /><br>-Eliciting doses in walnut allergic patients </p><br>
© Copyright 2025. All Rights Reserved by MedPath